Taurus Large Cap Fund
The scheme seeks to provide investors long-term capital appreciation. Investments shall be primarily in Equity and Equity related instruments of large cap companies.
Growthvine rating: 2/5 — ranked #30 of 41 in category.
Fund basics
| Category | Equity: Large Cap |
|---|
| NAV | ₹166.48 (as of 2026-08-21) |
|---|
| AUM | ₹52 Cr |
|---|
| Expense ratio | 2.08% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Anuj Kapil |
|---|
| Exit load | 1% for redemption within 365 days |
|---|
Performance & risk
| 5-year annualised return | 11.58% |
|---|
| Sharpe ratio | 0.55 |
|---|
| Standard deviation | 15.04% |
|---|
| Max drawdown | -67.77% |
|---|
| Alpha | 3.32 |
|---|
| Beta | 0.98 |
|---|
Over 5 years, captured 111.6% of NIFTY 100's upside and 110.1% of its downside.
Market cap allocation
| Large cap | 82.8% |
|---|
| Mid cap | 5.9% |
|---|
| Small cap | 11.3% |
|---|
Concentration
| Top 5 holdings | 33.3% |
|---|
| Top 10 holdings | 53.4% |
|---|
| Total holdings | 40 |
|---|
| Index overlap | 50.7% |
|---|
| Active share | 49.3% |
|---|
Top holdings
- Divis Laboratories Ltd. — 8.6%
- ITC Ltd — 7.6%
- ICICI Bank Ltd. — 6.8%
- HDFC Bank Ltd. — 5.5%
- SIGMA ADVANCED SYSTEMS LIMITED — 4.8%
- Advit Jewels Ltd. — 4.6%
- Bharti Airtel Ltd. — 4.5%
- Reliance Industries Ltd — 4.0%
- State Bank Of India — 3.6%
- HCL Technologies Ltd — 3.5%
Top sectors
- Banking & Financial — 23.4%
- Pharma & Biotech — 9.7%
- FMCG — 9.1%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 2.5% | Q1 (Top) | #5 of 39 |
| 2025 | 5.3% | Q3 | #27 of 36 |
| 2024 | 18.0% | Q1 (Top) | #8 of 32 |
| 2023 | 21.8% | Q3 | #24 of 32 |
| 2022 | 6.7% | Q1 (Top) | #5 of 28 |